Neurotox. neurotoxicity, and several pilot clinical BD-AcAc 2 trials have demonstrated cognitive improvements in HIV patients treated with GSK3 inhibitors. In addition to the GSK3 pathway, the CDK5 pathway has recently been implicated as a mediator of neurotoxicity in HIV, and HIV proteins might activate this pathway and subsequently disrupt the diverse processes that CDK5 […]